Nieinwazyjne biomarkery do wykrywania raka pęcherza moczowego

Bladder cancer (BC) is one of the most common cancer in the world. About 3% of all new cancer diagnoses are due to urinary bladder cancer. BC is also a leading cause of cancer-related death, as 2.1% of all cancer deaths are caused by bladder cancer. However, lack of a reliable biomarker is the biggest issue for BC diagnosis, prognosis and treatment. Development of non-invasive, quick and economical methods in bladder cancer diagnosis still remains a great challenge. Highly specific, easy-to-perform tests are really needed. Ideally if they can identify the presence of a tumor before the first symptoms appear, as time plays an important role in cancer. In this article, an overview of the current established diagnostic tests and newly identified biomarkers will be provided.